Melanie Marti

1.6k total citations · 1 hit paper
13 papers, 829 citations indexed

About

Melanie Marti is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Melanie Marti has authored 13 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Health and 7 papers in Epidemiology. Recurrent topics in Melanie Marti's work include Vaccine Coverage and Hesitancy (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Influenza Virus Research Studies (3 papers). Melanie Marti is often cited by papers focused on Vaccine Coverage and Hesitancy (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Influenza Virus Research Studies (3 papers). Melanie Marti collaborates with scholars based in Switzerland, Canada and United States. Melanie Marti's co-authors include Laure Dumolard, Noni E. MacDonald, Anita Kambhampati, Mona Marin, Jane F. Seward, Philippe Duclos, Joachim Hombach, Katherine L. O’Brien, Annelies Wilder‐Smith and Hanna Nohynek and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Vaccine.

In The Last Decade

Melanie Marti

12 papers receiving 807 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017

2018 391 citations Noni E. MacDonald, Melanie Marti et al. Vaccine profile →

Peers

Countries citing papers authored by Melanie Marti

Since Specialization

Citations

This map shows the geographic impact of Melanie Marti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Marti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Marti more than expected).

Fields of papers citing papers by Melanie Marti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Marti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Marti. The network helps show where Melanie Marti may publish in the future.

Co-authorship network of co-authors of Melanie Marti

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Marti. A scholar is included among the top collaborators of Melanie Marti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Marti. Melanie Marti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy 2025 ·Vaccines ·(unknown), Joachim Hombach, Melanie Marti	0
2	Global Status of Adult Immunization Post COVID-19 Pandemic 2025 ·Vaccines ·Alba Vilajeliu, (unknown), (unknown), Francisco Nogareda, (unknown), Donald Brooks, Charles Shey Wiysonge, Osman Çakmak, (unknown), Melanie Marti, Philipp Lambach, Stephanie Shendale, Marcela Contreras, (unknown), Erin Sparrow, Joachim Hombach, Ann Lindstrand	1
3	Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review 2024 ·Vaccines ·(unknown), Melanie Marti, Amit Goel, Rakesh Aggarwal	2
4	The Strategic Advisory Group of Experts (SAGE) on Immunization—Past, Present and Future 2024 ·Vaccines ·Melanie Marti, Hanna Nohynek, Philippe Duclos, Katherine L. O’Brien, Joachim Hombach	4
5	Use of existing systematic reviews for the development of evidence-based vaccination recommendations: Guidance from the SYSVAC expert panel 2023 ·Vaccine ·Antonia Pilic, Sarah Reda, (unknown), Helen Burchett, (unknown), Pauline Campbell, (unknown), (unknown), Benjamin M. Kagina, Wiebe Külper‐Schiek, Carole Lunny, Melanie Marti, Rudzani Muloiwa, Dawid Pieper, James Thomas, Matthew Tunis, (unknown), Ole Wichmann, Thomas Harder	6
6	Hepatitis E vaccine—Illuminating the barriers to use 2023 ·PLoS neglected tropical diseases ·Julia Lynch, Jacqueline Kyungah Lim, (unknown), T. Anh Wartel, Melanie Marti, (unknown), Helen Rees, Kawsar R. Talaat, Brittany Kmush, Rakesh Aggarwal, Iza Ciglenečki, Emily S. Gurley, Alain Labrique	18
7	Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review 2022 ·The Lancet Global Health ·Edward P K Parker, Shalini Desai, Melanie Marti, Hanna Nohynek, David C. Kaslow, Sonali Kochhar, Katherine L. O’Brien, Joachim Hombach, Annelies Wilder‐Smith	53
8	Using existing systematic reviews for developing vaccination recommendations: Results of an international expert workshop 2021 ·Vaccine ·(unknown), Helen Burchett, (unknown), Pauline Campbell, (unknown), (unknown), Benjamin M. Kagina, Carole Lunny, Melanie Marti, Rudzani Muloiwa, Dawid Pieper, James Thomas, Matthew Tunis, Ole Wichmann, (unknown), Thomas Harder	4
9	Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine 2021 ·Annelies Wilder‐Smith, Joachim Hombach, Melanie Marti, Katherine L. O’Brien	4
10	Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017 breakdown → 2018 ·Vaccine ·(unknown), Noni E. MacDonald, Melanie Marti, Laure Dumolard	391
11	Assessments of global drivers of vaccine hesitancy in 2014—Looking beyond safety concerns 2017 ·PLoS ONE ·Melanie Marti, (unknown), Noni E. MacDonald, Laure Dumolard, Philippe Duclos	130
12	Off-label use of vaccines 2017 ·Vaccine ·Pieter Neels, James F. Southern, Jon S. Abramson, Philippe Duclos, Joachim Hombach, Melanie Marti, (unknown), (unknown), Germaine Hanquet	19
13	Global Varicella Vaccine Effectiveness: A Meta-analysis 2016 ·PEDIATRICS ·Mona Marin, Melanie Marti, Anita Kambhampati, (unknown), Jane F. Seward	197

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact